
Advances in Brain Tumor Therapy
5 contributors - Paperback
£137.99
Thakur Gurjeet Singh, PhD, MPharm, has 16 years of experience in industry, research, and teaching. He is working as Dean, Chitkara College of Pharmacy, Chitkara University, Punjab, India. He is engaged with projects on interception of nicotine, morphine, alcohol dependence, ischemia, diabetic neuropathy and nephropathy toxicology, epilepsy, Alzheimer’s disease, and stem cell research studies and handles affiliation formalities with the director’s office. He has also attended UGC networking courses and various preclinical and clinical research training programs. He has more than 182 research publications (international and national) and 25 book chapters, eight books and 58 patents filed under his name. To date, he has 170 Scopus-indexed publications in peer-reviewed journals (with 1778 citations, an h-index 22 and i10-index 58, impact factor: 482.5 and RG score: 37). He has attended more than 60 national and international conferences. He has guided theses for 65 MPharm students and is supervising 10 PhD candidates. He is a reviewer for various highly reputed international journals. He is a member secretary of the Committee for the Purpose of Control and Supervision of Experiments on Animals and is the In-Charge of the animal house facility at Chitkara College of Pharmacy. He is also a member secretary for institutional human ethical committee registered with the Department of Health Research and CDSCO New Delhi, India.
Heena Khan, PhD, MPharm, has over five years of experience in research. She is working as a Junior Research Fellow. She is engaged with several projects on stroke, diabetes, Alzheimer’s disease, and Parkinson’s disease. She has more than 30 research and review publications (international), which have been cited in highly reputed journals. She is a reviewer for various highly reputed international journals. She has participated and attended several national and international conferences. She is also a member of the International Society for Pharmacoeconomics and Outcomes Research.